Cargando…
Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653882/ https://www.ncbi.nlm.nih.gov/pubmed/36361807 http://dx.doi.org/10.3390/ijms232113015 |
_version_ | 1784828791043915776 |
---|---|
author | Sun, Shuchan Dawuti, Awaguli Gong, Difei Wang, Ranran Yuan, Tianyi Wang, Shoubao Xing, Cheng Lu, Yang Du, Guanhua Fang, Lianghua |
author_facet | Sun, Shuchan Dawuti, Awaguli Gong, Difei Wang, Ranran Yuan, Tianyi Wang, Shoubao Xing, Cheng Lu, Yang Du, Guanhua Fang, Lianghua |
author_sort | Sun, Shuchan |
collection | PubMed |
description | There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possible mechanisms. By injecting 30 mg/kg of STZ intraperitoneally, diabetes was induced in rats. After a week of stability, the rats were injected subcutaneously with ISO (5 mg/kg). We randomly assigned the rats to eight groups: (1) control; (2) model; (3) metformin; (4–6) puerarin-V at different doses; (7) puerarin (API); (8) puerarin injection. DCM rats were found to have severe cardiac insufficiency (arrythmia, decreased LVdP/dt, and increased E/A ratio). In addition, cardiac injury biomarkers (cTn-T, NT-proBNP, AST, LDH, and CK-MB), inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α), and oxidative damage markers (MDA, SOD and GSH) were markedly increased. Treatment with puerarin-V positively adjusts these parameters mentioned above by improving cardiac function and mitochondrial respiration, suppressing myocardial inflammation, and maintaining the structural integrity of the cardiac muscle. Moreover, treatment with puerarin-V inhibits the P2X7 receptor-mediated pyroptosis pathway that was upregulated in diabetic hearts. Given these results, the current study lends credence to the idea that puerarin-V can reduce myocardial damage in DCM rats. Furthermore, it was found that the effect of puerarin-V in diabetic cardiomyopathy is better than the API, the puerarin injection, and metformin. Collectively, our research provides a new therapeutic option for the treatment of DCM in clinic. |
format | Online Article Text |
id | pubmed-9653882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96538822022-11-15 Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors Sun, Shuchan Dawuti, Awaguli Gong, Difei Wang, Ranran Yuan, Tianyi Wang, Shoubao Xing, Cheng Lu, Yang Du, Guanhua Fang, Lianghua Int J Mol Sci Article There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possible mechanisms. By injecting 30 mg/kg of STZ intraperitoneally, diabetes was induced in rats. After a week of stability, the rats were injected subcutaneously with ISO (5 mg/kg). We randomly assigned the rats to eight groups: (1) control; (2) model; (3) metformin; (4–6) puerarin-V at different doses; (7) puerarin (API); (8) puerarin injection. DCM rats were found to have severe cardiac insufficiency (arrythmia, decreased LVdP/dt, and increased E/A ratio). In addition, cardiac injury biomarkers (cTn-T, NT-proBNP, AST, LDH, and CK-MB), inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α), and oxidative damage markers (MDA, SOD and GSH) were markedly increased. Treatment with puerarin-V positively adjusts these parameters mentioned above by improving cardiac function and mitochondrial respiration, suppressing myocardial inflammation, and maintaining the structural integrity of the cardiac muscle. Moreover, treatment with puerarin-V inhibits the P2X7 receptor-mediated pyroptosis pathway that was upregulated in diabetic hearts. Given these results, the current study lends credence to the idea that puerarin-V can reduce myocardial damage in DCM rats. Furthermore, it was found that the effect of puerarin-V in diabetic cardiomyopathy is better than the API, the puerarin injection, and metformin. Collectively, our research provides a new therapeutic option for the treatment of DCM in clinic. MDPI 2022-10-27 /pmc/articles/PMC9653882/ /pubmed/36361807 http://dx.doi.org/10.3390/ijms232113015 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sun, Shuchan Dawuti, Awaguli Gong, Difei Wang, Ranran Yuan, Tianyi Wang, Shoubao Xing, Cheng Lu, Yang Du, Guanhua Fang, Lianghua Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors |
title | Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors |
title_full | Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors |
title_fullStr | Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors |
title_full_unstemmed | Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors |
title_short | Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors |
title_sort | puerarin-v improve mitochondrial respiration and cardiac function in a rat model of diabetic cardiomyopathy via inhibiting pyroptosis pathway through p2x7 receptors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653882/ https://www.ncbi.nlm.nih.gov/pubmed/36361807 http://dx.doi.org/10.3390/ijms232113015 |
work_keys_str_mv | AT sunshuchan puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT dawutiawaguli puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT gongdifei puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT wangranran puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT yuantianyi puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT wangshoubao puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT xingcheng puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT luyang puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT duguanhua puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors AT fanglianghua puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors |